Specialty Pharmacy

A look at last week's top stories in the world of pharmacy.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

IncobotulinumtoxinA is the first and only neurotoxin approved for this indication in the United States.

Using a DNA test to identify genetic variants in men that increase the likelihood of prostate cancer may help guide interventions for those at high risk and improve disease prevention.

Two recent studies examined the different effects and aspects of progressive multiple sclerosis.

Leticia Shea, PharmD, BCACP, who is an associate professor of pharmacy at Regis University, advises how pharmacists should approach counseling patients who are using medical cannabis.

Top news of the day from across the health care landscape.

In this video, Gordon Vanscoy, PharmD, MBA, explains how policy changes and science have allowed orphan drugs to enter the specialty pharmacy market and create hope for patients.

Using real-time symptom reports, a well-trained classification algorithm can detect lymphedema more accurately than current clinical methods.

Leticia Shea, PharmD, BCACP, who is an associate professor of pharmacy at Regis University, discusses why keeping up to date on the latest medical cannabis laws and research is important for guiding patients.

Atezolizumab (Tecentriq, Roche) plus chemotherapy nab-paclitaxel (Abraxane) met its co-primary endpoint of progression-free survival in patients with metastatic triple-negative breast cancer.

Between 33% and 38% of youth living with HIV use tobacco.

Top news of the day from across the health care landscape.

Officials with the FDA have approved Alkermes' aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults.

An investigational anti-cancer vaccine will be paired with nivolumab to determine whether the combination therapy will improve survival in patients with the disease.

The device, Pulmonx’s Zephyr Endobronchial Valve (Zephyr Valve) is a less invasive treatment than options currently available to patients.

Top news of the day from across the health care landscape.

Two recent clinical trials evaluated the efficacy of the drug ozanimod, an investigational drug for the treatment of relapsing multiple sclerosis.

Top news of the week from Specialty Pharmacy Times.

Ophthalmic compounding and dispensing can be an expensive and highly technical task.

Glasdegib, in addition to chemotherapy, offers an additional treatment option for patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

The study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.

How changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.

The massive online retailer is entering the online pharmacy world with its acquisition of PillPack.

Patients with melanoma who were treated with a combination of radiosurgery and anti-PD-1 immunotherapy experienced better outcomes compared with patients who received anti-CTLA4 immunotherapy.

Top news of the day from across the health care landscape

REMOXY ER is an abuse-deterrent, oral formulation of the widely prescribed opioid medication oxycodone.